menu
    • menu

    Company profile for Kodiak Sciences

    NEW Drugs in Dev: 5
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence ophthalmic diseases. Our team has the diversity of experience to build a leading biotech company. At Kodiak, we are working to develop disruptive products and platforms to prevent and treat the leading causes of blindness. Our biologics-based medicines are built on a proprietary high science Antibody Biopolyme...
    We are a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence ophthalmic diseases. Our team has the diversity of experience to build a leading biotech company. At Kodiak, we are working to develop disruptive products and platforms to prevent and treat the leading causes of blindness. Our biologics-based medicines are built on a proprietary high science Antibody Biopolymer Conjugate or ABC Platform designed to maintain potent and effective drug levels in key ocular tissues for longer than currently available therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kodiak SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2631 HANOVER STREET PALO ALTO, CA 94304
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kodiak.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kodiak-sciences-inc
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/kodiaksciences

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kodiak Sciences Reports Q1 2026 Results and Highlights
    Kodiak Sciences Reports Q1 2026 Results and Highlights

    07 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7303215

    FIRSTWORD PHARMA
    07 May 2026
    Share Share
    Kodiak Pipeline & KSI-101 Data at Key Conferences
    Kodiak Pipeline & KSI-101 Data at Key Conferences

    01 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-pipeline-advances-and-ksi-101-clinical-data-including-results-from-a-mesi-cohort-in-a-tertiary-care-uveitis-practice-at-upcoming-scientific-conferences-302759852.html

    PR NEWSWIRE
    01 May 2026
    Share Share
    Kodiak Sciences Announces Positive Topline Results in GLOW2
    Kodiak Sciences Announces Positive Topline Results in GLOW2

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kodiak-sciences-announces-positive-topline-results-in-glow2-the-second-phase-3-study-in-diabetic-retinopathy-demonstrating-superiority-of-zenkuda-tarcocimab-tedromer-over-sham-302725841.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share
    Kodiak Presents KSI-101 Data in Macular Edema at Angiogenesis
    Kodiak Presents KSI-101 Data in Macular Edema at Angiogenesis

    04 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/final-apex-phase-1b-clinical-results-for-kodiaks-ksi-101-in-macular-edema-secondary-to-inflammation-to-be-presented-at-angiogenesis-2026-302678453.html

    PR NEWSWIRE
    04 Feb 2026
    Share Share
    Kodiak Sciences Presents At J.P. Morgan Healthcare Conference
    Kodiak Sciences Presents At J.P. Morgan Healthcare Conference

    07 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-44th-annual-jp-morgan-healthcare-conference-302655850.html

    PR NEWSWIRE
    07 Jan 2026
    Share Share
    Kodiak Sciences Closes $184M Offering with Full Option Exercise
    Kodiak Sciences Closes $184M Offering with Full Option Exercise

    18 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kodiak-sciences-announces-closing-of-184-million-public-offering-of-common-stock-including-full-exercise-of-underwriters-option-to-purchase-additional-shares-302646525.html

    PR NEWSWIRE
    18 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search